Research

Energy balance

Long-term cardiovascular outcome data for recent anti-obesity medications remain inconclusive or lacking.

Practitioners should be cautious and consider the lack of long-term data when prescribing these medications.

StrongQualifiesmedium confidence
Their cardiometabolic benefits are modest, and long-term cardiovascular outcome data remain inconclusive or still lacking.
Haoyi Zheng · Cardiology Plus · 2025

Why this rating

Based on the review of available data in the abstract.

Source

Cardiovascular effects of anti-obesity medications: the perils and promise

Haoyi Zheng · Cardiology Plus · 2025

DOI 10.1097/cp9.0000000000000114

reviewCited 4×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →